Alzheimer's Disease: Related Targets, Synthesis of Available Drugs, Bioactive Compounds Under Development and Promising Results Obtained from Multi-target Approaches

Author(s): Natália F.F. Pirolla, Victor S. Batista, Flávia Pereira Dias Viegas, Vanessa Silva Gontijo, Caitlin R. McCarthy, Claudio Viegas*, Nailton M. Nascimento-Júnior*

Journal Name: Current Drug Targets

Volume 22 , Issue 5 , 2021


  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

We describe herein the therapeutic targets involved in Alzheimer’s disease as well as the available drugs and their synthetic routes. Bioactive compounds under development are also exploited to illustrate some recent research advances on the medicinal chemistry of Alzheimer’s disease, including structure-activity relationships for some targets. The importance of multi-target approaches, including some examples from our research projects, guides new perspectives in search of more effective drug candidates. This review comprises the period between 2001 and early 2020.

Keywords: Alzheimer's disease, structure-activity relationship, multi-target-directed ligands, acetylcholinesterase, nicotinic acetylcholine receptors, synthetic routes.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 22
ISSUE: 5
Year: 2021
Published on: 19 August, 2020
Page: [505 - 538]
Pages: 34
DOI: 10.2174/1389450121999200819144544
Price: $65

Article Metrics

PDF: 43